- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
Thailand’s Chulalongkorn University is developing an mRNA-based vaccine known as ChulaCov19.
Reuters reports that “Thailand will delay human trials of its coronavirus vaccine due to limited production capacity at overseas facilities.
“Thai health authorities had planned human testing of the vaccine by October but must delay that by several months. The delay will be a setback for Thailand’s push to quickly create its own vaccine.”
In an interview with the Bangkok Post, the leader of the project said that up to 30 million doses might be produced for Thailand and six other Asian countries if the vaccine proved to be safe and effective.
Countering Misinformation & Disinformation: Practical Training for Organizations
Practical skills to detect, verify, and respond across an evolving information landscape
Additional data provided by
English
Japanese
